Gabelli Healthcare & WellnessRx Trust(GRX)

upturn advisory logo
ADVISORIES YOU CAN VERIFY
QUALITY SIGNAL RECENCY
1-STAR RATING
Consider higher Upturn Star rating
BUY for 57 days
PROFIT SINCE LAST BUY
+7.18%
LAST CLOSE
$9.85
09/14/2026
(24-hour delay)

Advisory History & Simulated Performance *

*as per simulation (see disclosures)
  • ALL
  • 1Y
  • 1M
  • 1W
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • PASS (Skip)
Upturn Stock price based on last close iconStock price based on last close

Advisory Performance History (Simulated)Advisory Performance History info

Upturn Advisory & Investor View for GRX

09/14/2026: GRX (1-star) has a low Upturn Star Rating. Not recommended to BUY.

Gabelli Healthcare & WellnessRx Trust (GRX) is a closed-end fund providing exposure to the global healthcare and wellness sectors. The fund is designed for investors seeking regular monthly income alongside potential capital appreciation, leveraging the research-intensive management style of Gabelli Funds. Its primary strength lies in its specialized, active approach to identifying value in biotech, pharma, and health-related wellness. However, investors face risks including share price volatility, potential discounts to net asset value, and sector-specific regulatory headwinds. The fund is best suited for income-focused investors who understand the risks of active sector-specific funds and wish to monitor distributions and the fund's trading premium or discount regularly.

How to Read the Upturn Advisory

The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.

Company fundamentals, valuation, risks, and news provide supporting context about the business.

Investor Fit

Investor styleFitWhy
Growth investorMixed fitWhile it focuses on growth sectors like biotech, the fund's income mandate may limit pure capital appreciation potential.
Momentum investorWeak fitThe fund is generally managed for long-term thematic exposure rather than capturing short-term market momentum.
Value investorStrong fitThe Gabelli approach is fundamentally rooted in identifying undervalued assets, which aligns well with value investing principles.
Dividend investorStrong fitThe fund is specifically structured to provide regular monthly distributions to investors.
Low-risk investorWeak fitAs an equity-focused closed-end fund with sector concentration, it carries significant market and volatility risk.

Risk Profile

Risk factorLevelWhy it matters
Price volatilityMedium / highAs an equity CEF, the fund's market price can fluctuate significantly based on market sentiment.
Valuation riskMediumThe share price may trade at a premium or discount to the underlying Net Asset Value.
Competition risk (healthcare sector concentration)MediumConcentration in a single sector makes the fund vulnerable to regulatory and political changes in healthcare.
Business qualityStrongThe fund employs a disciplined, research-intensive investment process backed by a veteran management team.
Dividend incomeMediumDistributions are not guaranteed and can fluctuate based on the income generated by the portfolio.
Execution riskMediumThe manager's ability to pick successful stocks within the complex healthcare sector is key to performance.

Price Behavior

Steady Uptrend
PRICE PATH

Steady Uptrend

The stock demonstrates consistent and steady upward price momentum.

Very Smooth
PRICE STABILITY

Very Smooth

The stock has followed a highly orderly price path with minimal short-term disruption.

Analysis of Past Performance

Type Stock
Historic Profit 18.04%
Avg. Invested days 56
Today’s Advisory Consider higher Upturn Star rating
Upturn Advisory Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 3.0
Stock Returns Performance Upturn Returns Performance icon 2.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 09/14/2026

Upturn Scorecard

Upturn Star Rating

GRX receives a 3-star rating, supported by strong unit economics, and solid company fundamentals. The rating is constrained by soft analyst coverage, and weak price momentum.

Company Fundamentals

GRX has solid overall fundamentals (4 stars), with solid financial health, solid growth momentum, and moderate ownership. In FY2025 versus FY2024, strong earnings growth (+905.1%) and strong cash generation (FCF margin 61.8%) are partially offset by modest insider ownership of 1.77%.

Financial Health Rating

GRX's financial health is supported by solid cash strength, including free-cash-flow generation (61.8% of revenue). Liquidity is moderate (3 stars), which helps explain the 4-star overall score.

Growth Momentum Score

Earnings growth is GRX's strongest growth driver at +905.1% FY2025 versus FY2024 (strong, 5 stars). By comparison, revenue growth (+368.7%, strong) is also strong, while free-cash-flow growth (-28.0%, negative) holds the profile back, so recent growth is not broad-based across the business.

Ownership

Institutional ownership is 41.0% and approximately 0.0% of outstanding shares are publicly tradable, supporting liquidity and institutional participation. Insider ownership of 1.77% provides only moderate management-shareholder alignment.

Unit Economics (Per $1K Revenue)

GRX generates approximately $837 of gross profit, $310 of operating income, and $618 of free cash flow for every $1,000 of revenue. Based on FY2025 results. Strong cash conversion and healthy margins support the rating, although capital efficiency remains below the highest tier.

Economic Dimensions

Effective Tax Rate: 0.00%

Quantitative Style Profile

GRX has a relatively low-volatility profile. Weak momentum is the primary drawback, while valuation that is moderately attractive rather than deeply discounted.

Style Classification

Quality Focused

Low VolatilitySmall / Mid Cap Risk

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 141.37M USD
Price to earnings Ratio 17.05
1Y Target Price -
Price to earnings Ratio 17.05
1Y Target Price -
Volume (30-day avg) 22.8K shares
Beta -
52 Weeks Range 8.47 - 10.20
Updated Date 09/14/2026
52 Weeks Range 8.47 - 10.20
Updated Date 09/14/2026
Dividends yield (FY) -
Basic EPS (TTM) 0.57

How Company Makes Money

Business areaWhat it includesRetail investor read
Investment PortfolioHoldings in pharmaceutical, biotech, and wellness companies.You earn money from dividends and potential share price growth generated by the underlying healthcare stocks.
Advertisement

Valuation

Trailing PE 17.05
Forward PE -
Enterprise Value -
Price to Sales(TTM) 16.92
Enterprise Value -
Price to Sales(TTM) 16.92
Enterprise Value to Revenue 15.96
Enterprise Value to EBITDA -
Shares Outstanding 14.54M
Shares Floating -
Shares Outstanding 14.54M
Shares Floating -
Percent Insiders 1.77
Percent Institutions 41.02

Icon representing Upturn AI-generated SWOT analysis summary Upturn AI Summary

Information icon for Upturn AI Summarization accuracy disclaimer AI Summarization is directionally correct and might not be accurate.

Information icon for Upturn AI Summarization data freshness disclaimer Summarized information shown could be a few years old and not current.

Information icon warning about Upturn AI Fundamental Rating based on potentially old data Fundamental Rating based on AI could be based on old data.

Information icon warning about potential inaccuracies or hallucinations in Upturn AI-generated summaries AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

Financial Metrics

🧭 Investment Snapshot

Total Revenue (Scale)

Information icon Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.

Net Income (Profit)

Information icon Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.

Free Cash Flow (Cash Strength)

Information icon Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.

📈 Growth & Strength

Operating Income (Core Profit)

Information icon Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.

EBITDA (Cash Earnings)

Information icon Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.

Gross Profit (Unit Profitability)

Information icon Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.

🛡️ Financial Safety

Cash (Liquidity Buffer)

Information icon Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.

Total Debt (Leverage Risk)

Information icon Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.

Net Working Capital (Short-Term Health)

Information icon Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.

🧱 Balance Sheet Strength

Stockholder Equity (Net Worth)

Information icon Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.

Total Assets (Asset Base)

Information icon The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.

Income Before Tax (Pre-Tax Earnings)

Information icon Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.

⚙️ Cost & Drag Factors

Cost of Revenue (Production Cost)

Information icon Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.

Total Operating Expenses (Operating Cost)

Information icon Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.

Income Tax Expense (Tax Drag)

Information icon Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

About Gabelli Healthcare & WellnessRx Trust

Exchange NYSE
Headquarters Rye, NY, United States
IPO Launch date 2007-06-19
CEO -
Sector Financial Services
Industry Asset Management
Full time employees -
Full time employees -

The Gabelli Healthcare & Wellness Trust is a closed-ended equity mutual fund launched by GAMCO Investors, Inc. The fund is managed by Gabelli Funds, LLC. It invests in the public equity markets across the globe. The fund seeks to invest in stocks of companies primarily operating in the healthcare and wellness sector. It invests in stocks of companies across all market capitalizations. The fund benchmarks the performance of its portfolio against the S&P 500 Index, S&P 500 Consumer Staples Index, and S&P 500 Health Care Index. The Gabelli Healthcare & Wellness Trust was formed on February 20, 2007 and is domiciled in the United States.